Immunic to Participate in Scientific and Medical Conferences in April

NEW YORK, April 9, 2026 /PRNewswire/ -- Immunic , Inc.  (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following scientific and medical conferences in April: April 14-16: 8th Annual Neuroimmunology Drug Development Summit. Hella Kohlhof, Ph.D.